GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hunan Hansen Pharmaceutical Co Ltd (SZSE:002412) » Definitions » Sale Of Investment

Hunan Hansen Pharmaceutical Co (SZSE:002412) Sale Of Investment : ¥1,133 Mil (TTM As of Mar. 2025)


View and export this data going back to 2011. Start your Free Trial

What is Hunan Hansen Pharmaceutical Co Sale Of Investment?

Hunan Hansen Pharmaceutical Co's sale of investment for the three months ended in Mar. 2025 was ¥298 Mil. It means Hunan Hansen Pharmaceutical Co gained ¥298 Mil from selling investments. Hunan Hansen Pharmaceutical Co's sale of investment for the trailing twelve months (TTM) ended in Mar. 2025 was ¥1,133 Mil.

Compared with last quarter (¥277 Mil in Dec. 2024 ), Hunan Hansen Pharmaceutical Co gained more money from selling investments in Mar. 2025 (¥298 Mil).


Hunan Hansen Pharmaceutical Co Sale Of Investment Historical Data

The historical data trend for Hunan Hansen Pharmaceutical Co's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hunan Hansen Pharmaceutical Co Sale Of Investment Chart

Hunan Hansen Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Sale Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only 35.50 242.06 305.58 1,010.71 1,018.97

Hunan Hansen Pharmaceutical Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 184.43 312.93 244.40 277.21 297.97

Hunan Hansen Pharmaceutical Co Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1,133 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hunan Hansen Pharmaceutical Co Sale Of Investment Related Terms

Thank you for viewing the detailed overview of Hunan Hansen Pharmaceutical Co's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


Hunan Hansen Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
Silver City Road, Long Ridge Industrial Park, Heshan District, Yiyang City, CHN, 413000
Hunan Hansen Pharmaceutical Co Ltd is producing Chinese and Western medicines. Its main dosage forms include large-volume injections, small-volume injections, oral liquids, tablets, hard capsules, granules, syrups, ointments, tinctures, and pills. The company's main products are Si Mo Tang Oral Liquid, Shuanquan Capsule, Ginkgo Biloba Capsule and Tianma Xingnao Capsule.
Executives
Luo Yong Qing Directors, executives
Liu Zheng Qing Directors, executives
Liu Ling An Director
Fu Jian Jun Executives
Liu Na Xin Independent director
Liu Hou Yao Directors, Directors, and Executives
He San Xing Directors, executives

Hunan Hansen Pharmaceutical Co Headlines

No Headlines